MENU
FATE
AS OF
Nov 19, 04:59 PM (EDT)
Price
$1.06
Change
+$0.04 (+3.92%)
Capitalization
117.66M
103 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
FATE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Fate Therapeutics (FATE) Earnings Date & Reports

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

FATE is expected to report earnings to fall 1.56% to -26 cents per share on March 02

Fate Therapeutics FATE Stock Earnings Reports
Q4'25
Est.
$-0.27
Q3'25
Beat
by $0.03
Q2'25
Beat
by $0.05
Q1'25
Beat
by $0.07
Q4'24
Est.
$-0.44
The last earnings report on November 13 showed earnings per share of -27 cents, beating the estimate of -30 cents. With 969.80K shares outstanding, the current market capitalization sits at 117.66M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
FATE
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. FATE showed earnings on November 13, 2025. You can read more about the earnings report here.
View AI-Driven Trading for FATE
A.I. Advisor
published General Information

General Information

a clinical stage biopharmaceutical company

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
12278 Scripps Summit Drive
Phone
+1 858 875-1800
Employees
220
Web
https://www.fatetherapeutics.com